Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

xPORT Lens Fragmentation System

K-Number: K191024 · 2019-08-13

Decision Date2019-08-13
Product CodeHQC
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

xPORT Lens Fragmentation System is a medical device manufactured by Carl Zeiss Meditec Cataract Technology, Inc.. It received FDA 510(k) clearance on 2019-08-13 under approval number K191024. The device is classified under product code HQC. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the xPORT Lens Fragmentation System?

xPORT Lens Fragmentation System is a medical device that received FDA 510(k) clearance on 2019-08-13. It is manufactured by Carl Zeiss Meditec Cataract Technology, Inc.. The 510(k) number is K191024.

When was xPORT Lens Fragmentation System approved by the FDA?

xPORT Lens Fragmentation System received FDA 510(k) clearance on 2019-08-13, under approval number K191024.

What company makes xPORT Lens Fragmentation System?

xPORT Lens Fragmentation System is manufactured by Carl Zeiss Meditec Cataract Technology, Inc..

What is the FDA product code for xPORT Lens Fragmentation System?

The FDA product code for xPORT Lens Fragmentation System is HQC.

Related Clinical Trials

Other Devices by Carl Zeiss Meditec Cataract Technology, Inc.

View all 7 devices →

Related Devices (Code: HQC)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.